In the recent Everything Hormones, we discussed the “myths” of not prescribing hormones for certain categories of high-risk patients, though providers need to understand the science and individualize it, such as those with:
Hyper-coagulable genetic disorders like Factor V Leiden
High-risk cardiac patients like post MI, stroke, or with congestive heart failure
High-risk survivors of hormonally driven cancers with a focus on breast and prostate cancers